Best Practices: Evolving Understanding of Molecular Diagnostics and Biomarkers in Lung Cancer.
- Published in:
- 2018
- Publication type:
- Interview
Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 9
Results: 9
1
2
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 37
- By:
- Publication type:
- Article
3
Selective RET Inhibitor, BLU-667, Hits the Target in Patients with Lung or Thyroid Cancers.
- Published in:
- 2018
- By:
- Publication type:
- Product Review
4
Timing of Palliative Care Consults Key in Elderly Patients with Pancreatic Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 19
- By:
- Publication type:
- Article
5
Building on the Successes of Cancer Immunotherapy.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 16
- By:
- Publication type:
- Article
6
Managing Cancer-Related Fatigue and Insomnia in Patients and Caregivers.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 9
- By:
- Publication type:
- Article
7
MSI-H a Marker for Lynch Syndrome, a More Common Condition Than Generally Expected.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 1
- By:
- Publication type:
- Article
8
Dispelling Misconceptions About HCC Coding.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 1
- By:
- Publication type:
- Article
9
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 9, p. 1
- By:
- Publication type:
- Article